WallStreetZenWallStreetZen

NYSE: AGL
Agilon Health Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for AGL

Based on 3 analysts offering 12 month price targets for Agilon Health Inc

Min Forecast
$0.50+5.93%
Avg Forecast
$0.92+94.28%
Max Forecast
$1.50+217.8%

Should I buy or sell AGL stock?

Based on 3 analysts offering ratings for Agilon Health Inc.

Hold
Strong Buy
1 analysts 33.33%
Buy
0 analysts 0%
Hold
1 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
1 analysts 33.33%

Be the first to know when Wall Street analysts revise their AGL stock forecasts and price targets.

AGL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-03-03
lockedlocked$00.00+00.00%2026-02-27
lockedlocked$00.00+00.00%2026-02-27

1 of 1

Forecast return on equity

Is AGL forecast to generate an efficient return?

Company
N/A
Industry
-110.41%
Market
179.62%

Forecast return on assets

Is AGL forecast to generate an efficient return on assets?

Company
N/A
Industry
13.31%

AGL earnings per share forecast

What is AGL's earnings per share in the next 3 years based on estimates from 18 analysts?

Avg 1 year Forecast
-$0.35
Avg 2 year Forecast
-$0.22
Avg 3 year Forecast
-$0.11

AGL revenue forecast

What is AGL's revenue in the next 3 years based on estimates from 18 analysts?

Avg 1 year Forecast
$5.5B-7.04%
Avg 2 year Forecast
$5.8B-2.37%
Avg 3 year Forecast
$6.6B+10.71%
AGL's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

AGL revenue growth forecast

How is AGL forecast to perform vs Medical Care Facilities companies and vs the US market?

Company
2.71%
Industry
5.25%
Market
13.42%
AGL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
AGL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

AGL vs Medical Care Facility Stocks

TickerPricePrice TargetUp/downsideConsensus
AGL$0.47$0.92+94.28%Hold
AIRS$2.72N/AN/A
JYNT$8.17N/AN/A
NAKA$0.24$0.50+108.33%Strong Buy
CCRN$9.35$12.67+35.48%Buy
View Top Medical Care Facility Stocks

Agilon Health Stock Forecast FAQ

Is Agilon Health Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NYSE: AGL) stock is to Hold AGL stock.

Out of 3 analysts, 1 (33.33%) are recommending AGL as a Strong Buy, 0 (0%) are recommending AGL as a Buy, 1 (33.33%) are recommending AGL as a Hold, 0 (0%) are recommending AGL as a Sell, and 1 (33.33%) are recommending AGL as a Strong Sell.

If you're new to stock investing, here's how to buy Agilon Health stock.

What is AGL's earnings growth forecast for 2026-2028?

(NYSE: AGL) Agilon Health's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Care Facilities industry's average forecast earnings growth rate of 10.55%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 35.93%.

Agilon Health's earnings in 2026 is -$391,347,000.On average, 18 Wall Street analysts forecast AGL's earnings for 2026 to be -$145,494,824, with the lowest AGL earnings forecast at -$211,417,629, and the highest AGL earnings forecast at -$78,410,384. On average, 15 Wall Street analysts forecast AGL's earnings for 2027 to be -$93,179,748, with the lowest AGL earnings forecast at -$166,694,669, and the highest AGL earnings forecast at -$21,780,662.

In 2028, AGL is forecast to generate -$46,092,030 in earnings, with the lowest earnings forecast at -$117,905,986 and the highest earnings forecast at $30,492,927.

What is AGL's revenue growth forecast for 2026-2028?

(NYSE: AGL) Agilon Health's forecast annual revenue growth rate of 2.71% is not forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 5.25%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.42%.

Agilon Health's revenue in 2026 is $5,932,576,000.On average, 18 Wall Street analysts forecast AGL's revenue for 2026 to be $2,288,006,720,885, with the lowest AGL revenue forecast at $2,200,469,201,736, and the highest AGL revenue forecast at $2,393,798,509,430. On average, 15 Wall Street analysts forecast AGL's revenue for 2027 to be $2,402,925,644,128, with the lowest AGL revenue forecast at $2,184,289,281,135, and the highest AGL revenue forecast at $2,638,571,667,240.

In 2028, AGL is forecast to generate $2,724,864,577,112 in revenue, with the lowest revenue forecast at $2,268,507,842,212 and the highest revenue forecast at $3,341,775,908,745.

What is AGL's forecast return on assets (ROA) for 2026-2029?

(NYSE: AGL) forecast ROA is N/A, which is lower than the forecast US Medical Care Facilities industry average of 13.31%.

What is AGL's Price Target?

According to 3 Wall Street analysts that have issued a 1 year AGL price target, the average AGL price target is $0.92, with the highest AGL stock price forecast at $1.50 and the lowest AGL stock price forecast at $0.50.

On average, Wall Street analysts predict that Agilon Health's share price could reach $0.92 by Mar 3, 2027. The average Agilon Health stock price prediction forecasts a potential upside of 94.28% from the current AGL share price of $0.47.

What is AGL's Earnings Per Share (EPS) forecast for 2026-2028?

(NYSE: AGL) Agilon Health's current Earnings Per Share (EPS) is -$0.95. On average, analysts forecast that AGL's EPS will be -$0.35 for 2026, with the lowest EPS forecast at -$0.51, and the highest EPS forecast at -$0.19. On average, analysts forecast that AGL's EPS will be -$0.22 for 2027, with the lowest EPS forecast at -$0.40, and the highest EPS forecast at -$0.05. In 2028, AGL's EPS is forecast to hit -$0.11 (min: -$0.28, max: $0.07).

What is AGL's forecast return on equity (ROE) for 2026-2029?

(NYSE: AGL) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.